Dr. Martens plc (LON:DOCS – Get Free Report) insider Kenny Wilson acquired 226 shares of the firm’s stock in a transaction that occurred on Wednesday, September 11th. The stock was acquired at an average cost of GBX 67 ($0.88) per share, with a total value of £151.42 ($198.01).
Kenny Wilson also recently made the following trade(s):
- On Thursday, July 11th, Kenny Wilson bought 200 shares of Dr. Martens stock. The stock was purchased at an average price of GBX 75 ($0.98) per share, with a total value of £150 ($196.16).
Dr. Martens Price Performance
DOCS remained flat at GBX 63.30 ($0.83) during trading on Thursday. The company’s stock had a trading volume of 840,013 shares, compared to its average volume of 1,969,112. The stock has a market cap of £608.77 million, a price-to-earnings ratio of 904.29, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 129.55. Dr. Martens plc has a 12-month low of GBX 62 ($0.81) and a 12-month high of GBX 155.50 ($2.03). The stock has a fifty day simple moving average of GBX 70.97 and a 200 day simple moving average of GBX 79.63.
Dr. Martens Company Profile
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Read More
- Five stocks we like better than Dr. Martens
- Buy P&G Now, Before It Sets A New All-Time High
- 3 Leveraged ETFs to Multiply Returns
- Business Services Stocks Investing
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- Why Are Stock Sectors Important to Successful Investing?
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.